1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Clinical Research Advantage Acquires CCD - Late Phase Division

M&A Deal Summary

Clinical Research Advantage Acquires CCD - Late Phase Division

On July 1, 2013, Clinical Research Advantage acquired life science company CCD - Late Phase Division from Comprehensive Clinical Development

Acquisition Highlights
  • This is Clinical Research Advantage’s 2nd transaction in the Life Science sector.
  • This is Clinical Research Advantage’s 2nd transaction in the United States.

M&A Deal Summary
Date 2013-07-01
Target CCD - Late Phase Division
Sector Life Science
Buyer(s) Clinical Research Advantage
Sellers(s) Comprehensive Clinical Development
Deal Type Divestiture

Target

CCD - Late Phase Division

United States
CCD’s Late Phase Division is an industry leader in conducting psychiatric clinical trials, specifically in the areas of Schizophrenia, Bipolar Disorder, Depression, and Alzheimer's Disease, and operates four independent sites in Atlanta (GA), Cerritos (CA), Holliswood (NY) and Washington, D.C.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Clinical Research Advantage

Tempe, Arizona, United States
Category Company
Founded 1990
Sector Life Science
DESCRIPTION

Clinical Research Advantage, Inc. is a provider of research services to the pharmaceutical and medical device industries since 1990, and has successfully completed over 12,000 clinical trials. The Company matches pharmaceutical, biotechnology and contract research organizations with its partner medical practices to recruit patients and conduct clinical trials.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 2 of 2
Year: 2013 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-22 Radiant Research

Tempe, Arizona, United States

Radiant Research is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant employs over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.

Buy -

Seller(S) 1

SELLER

Comprehensive Clinical Development

Miramar, Florida, United States
Category Company
Founded 1994
Sector Life Science
DESCRIPTION

Comprehensive Clinical Development is clinical research company focusing on clinical central nervous system (CNS) .

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 2 of 2
Country: United States M&A 2 of 2
Year: 2013 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-01 CCD - Early Development Division

United States

CCD’s Early Development Division, operating out of a state-of-the-art clinical research facility in Miramar, Florida, has significant expertise in complex Phase I - IIa studies and maintains a sizable database of well-characterized healthy volunteers and disease state special populations.

Sell -
Mergr

Solution for

Product

Company

Legal